Literature DB >> 26936620

Relationship of Right Ventricular Size and Function with Respiratory Status in Duchenne Muscular Dystrophy.

Muddassir Mehmood1, Stephanie A Ambach2, Michael D Taylor3, John L Jefferies3, Subha V Raman4, Robin J Taylor5, Hemant Sawani3, Jacob Mathew3, Wojciech Mazur6, Kan N Hor7, Hussein R Al-Khalidi8.   

Abstract

The relationship between pulmonary function and right ventricle (RV) in Duchenne muscular dystrophy (DMD) has not been evaluated. Using cardiac magnetic resonance (CMR), we describe the relationship of RV size and function with spirometry in a DMD cohort. Fifty-seven boys undergoing CMR and pulmonary function testing within 1 month at a single center (2013-2015) were enrolled. Comparisons of RV ejection fraction (RVEF) and end-diastolic volume index (RVEDVI) were made across categories of percent forced vital capacity (FVC%), and relationships were assessed. Mean age was 15.5 ± 3.5 years. Spirometry and CMR were performed within 3.9 ± 4.1 days. Median FVC% was 92.0 % (67.5-116.5 %). Twenty-three (40 %) patients had abnormal FVC% (<80 %) of which 13 (57 %) had mild (FVC% 60-79 %), 6 (26 %) had moderate (FVC% 40-59 %), and 4 (17 %) had severe (FVC <40 %) reductions. Mean RVEF was 58.3 ± 3.7 %. Patients with abnormal FVC% were older and had lower RVEF and RVEDVI. Both RVEF and RVEDVI were significantly associated with FVC% (r = 0.31, p = 0.02 and r = 0.39, p = 0.003, respectively). In a large DMD cohort, RVEF and RVEDVI were related to FVC%. Worsening respiratory status may guide monitoring of cardiac function in these patients.

Entities:  

Keywords:  Cardiac magnetic resonance; Duchenne muscular dystrophy; Pulmonary function testing; Right ventricular function; Right ventricular volume

Mesh:

Year:  2016        PMID: 26936620     DOI: 10.1007/s00246-016-1362-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

Review 1.  Quantification in cardiac MRI.

Authors:  R J van der Geest; J H Reiber
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

2.  Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images.

Authors:  R J van der Geest; V G Buller; E Jansen; H J Lamb; L H Baur; E E van der Wall; A de Roos; J H Reiber
Journal:  J Comput Assist Tomogr       Date:  1997 Sep-Oct       Impact factor: 1.826

3.  The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article.

Authors:  David J Birnkrant; Katharine M D Bushby; Raouf S Amin; John R Bach; Joshua O Benditt; Michelle Eagle; Jonathan D Finder; Maninder S Kalra; John T Kissel; Anastassios C Koumbourlis; Richard M Kravitz
Journal:  Pediatr Pulmonol       Date:  2010-08

4.  Respiratory complications of the muscular dystrophies.

Authors:  Anita K Simonds
Journal:  Semin Respir Crit Care Med       Date:  2002-06       Impact factor: 3.119

5.  Right ventricular dilatation, right ventricular wall thickening, and Doppler evidence of pulmonary hypertension in patients with a pure restrictive ventilatory impairment.

Authors:  K Shivkumar; K Ravi; J W Henry; M Eichenhorn; P D Stein
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

6.  Prolongation of life in Duchenne's muscular dystrophy.

Authors:  Y Rideau; G Gatin; J Bach; G Gines
Journal:  Acta Neurol (Napoli)       Date:  1983-04

7.  Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.

Authors:  Janne Mykland Hilde; Ingunn Skjørten; Ole Jørgen Grøtta; Viggo Hansteen; Morten Nissen Melsom; Jonny Hisdal; Sjur Humerfelt; Kjetil Steine
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

8.  Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study.

Authors:  Steven M Kawut; Hooman D Poor; Megha A Parikh; Katja Hueper; Benjamin M Smith; David A Bluemke; João A C Lima; Martin R Prince; Eric A Hoffman; John H M Austin; Jens Vogel-Claussen; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2014-11-03       Impact factor: 24.094

9.  Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy.

Authors:  A Baydur; I Gilgoff; W Prentice; M Carlson; D A Fischer
Journal:  Chest       Date:  1990-04       Impact factor: 9.410

10.  All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy.

Authors:  Gernot Schram; Anne Fournier; Hugues Leduc; Nagib Dahdah; Johanne Therien; Michel Vanasse; Paul Khairy
Journal:  J Am Coll Cardiol       Date:  2013-01-23       Impact factor: 24.094

View more
  3 in total

1.  Cardiac function associated with home ventilator care in Duchenne muscular dystrophy.

Authors:  Sangheun Lee; Heeyoung Lee; Lucy Youngmin Eun; Seung Woong Gang
Journal:  Korean J Pediatr       Date:  2018-02-28

2.  Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids.

Authors:  Megan E Angliss; Kiara D Sclip; Leanne Gauld
Journal:  BMJ Open Respir Res       Date:  2020-02

3.  Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.

Authors:  Corinne A Betts; Graham McClorey; Richard Healicon; Suzan M Hammond; Raquel Manzano; Sofia Muses; Vicky Ball; Caroline Godfrey; Thomas M Merritt; Tirsa van Westering; Liz O'Donovan; Kim E Wells; Michael J Gait; Dominic J Wells; Damian Tyler; Matthew J Wood
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.